Epidemiology of Biomarkers of AMD Progression

AMD 进展生物标志物的流行病学

基本信息

  • 批准号:
    10489288
  • 负责人:
  • 金额:
    $ 58.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-30 至 2027-08-31
  • 项目状态:
    未结题

项目摘要

Project Abstract There are currently no effective treatments for atrophic age-related macular degeneration (AMD), in part because we may be intervening too late in the disease course after geographic atrophy (GA) has developed. A far preferable strategy would be to intervene at an earlier phase of the disease, but there is uncertainty with regards to disease biomarkers to select the most appropriate patients as well as endpoints which could be used to conduct an interventional trial in a clinically-practical time-frame. This is in large part because of the lack of a sufficiently granular staging system describing the progression from early to late stage AMD. The best currently available data comes from studies such as the Age-Related Eye Diseases Study and the Beaver Dam Eye Study, but these studies were largely based on color fundus photographs with AMD disease features assessed using historical protocols developed in the film-based imaging era. The AMD disease severity scales and staging systems built from these studies are insufficiently granular and fail to take advantage of modern, pervasive digital imaging technologies such as optical coherence tomography (OCT) and OCT angiography (OCT-A) which readily lend themselves to quantification. Extensive research over the past decade has identified a number of structural OCT features of AMD, such as intraretinal hyper-reflective foci and subretinal drusenoid deposits, which appear to increase the risk for developing late AMD (atrophy and/or neovascularization). More recently, choriocapillaris (CC) flow deficits have been shown to increase with age and in AMD. The relationship between CC flow deficits and the onset and stage of AMD still remains to be defined. In addition, although a number of genetic risk factors for AMD have been identified, the genetics of AMD progression are not yet elucidated. This research application proposes to address these critical knowledge gaps by evaluating elderly subjects with AMD who have previously been recruited as part of the NEI-funded Amish Eye Study. The Amish represent a homogenous population with regards to environmental and social exposures which reduces variability and makes this group ideally suited for epidemiologic studies of AMD progression. Through that previous study, baseline (and some 2-year follow up) clinical, multimodal imaging (including OCT), and genetic data have already been collected. However, long-term (7 year) data, which will be a focus of our proposed research, is critical to actually establish which individuals go on to progress to late AMD, which is vital in order to determine which baseline features are associated with a higher risk of progression, and to develop a granular and quantitative staging system for AMD. The development of this novel AMD staging system will provide points of intervention and outcome assessment to enable early intervention clinical trials and provide new insights into the genetics and pathophysiology of AMD.
项目摘要

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Longitudinal evaluation of the distribution of intraretinal hyper-reflective foci in eyes with intermediate age-related macular degeneration.
中度年龄相关性黄斑变性眼视网膜内高反射灶分布的纵向评估。
  • DOI:
    10.21203/rs.3.rs-3273570/v1
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sadda,Srinivas;Verma,Aditya;Corradetti,Giulia;Nittala,Muneeswar;He,Ye;Nassisi,Marco;Velaga,SwethaBindu;Haines,Jonathan;Pericak-Vance,Margaret;Stambolian,Dwight
  • 通讯作者:
    Stambolian,Dwight
Enhanced Detection of Reticular Pseudodrusen on Color Fundus Photos by Image Embossing.
  • DOI:
    10.1080/02713683.2022.2126860
  • 发表时间:
    2022-11
  • 期刊:
  • 影响因子:
    2
  • 作者:
  • 通讯作者:
Drusen morphometrics on optical coherence tomography in eyes with age-related macular degeneration and normal aging.
  • DOI:
    10.1007/s00417-023-06088-z
  • 发表时间:
    2023-09
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Oncel, Deniz;Corradetti, Giulia;Wakatsuki, Yu;Nittala, Muneeswar Gupta;Velaga, Swetha Bindu;Stambolian, Dwight;Pericak-Vance, Margaret A.;Haines, Jonathan L.;Sadda, SriniVas R.
  • 通讯作者:
    Sadda, SriniVas R.
Risk Factors for Progression of Age-Related Macular Degeneration: Population-Based Amish Eye Study.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jonathan L Haines其他文献

Jonathan L Haines的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jonathan L Haines', 18)}}的其他基金

Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL
阿米什人阿尔茨海默病的保护性遗传变异 - RENEWAL
  • 批准号:
    10448612
  • 财政年份:
    2022
  • 资助金额:
    $ 58.26万
  • 项目类别:
Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL
阿米什人阿尔茨海默病的保护性遗传变异 - RENEWAL
  • 批准号:
    10689703
  • 财政年份:
    2022
  • 资助金额:
    $ 58.26万
  • 项目类别:
Data Management and Statistics Core
数据管理和统计核心
  • 批准号:
    10675656
  • 财政年份:
    2021
  • 资助金额:
    $ 58.26万
  • 项目类别:
Data Management and Statistics Core
数据管理和统计核心
  • 批准号:
    10474597
  • 财政年份:
    2021
  • 资助金额:
    $ 58.26万
  • 项目类别:
Data Management and Statistics Core
数据管理和统计核心
  • 批准号:
    10263711
  • 财政年份:
    2021
  • 资助金额:
    $ 58.26万
  • 项目类别:
Protective Genetic Variants for Alzheimer Disease in the Amish
阿米什人阿尔茨海默病的保护性遗传变异
  • 批准号:
    9439190
  • 财政年份:
    2017
  • 资助金额:
    $ 58.26万
  • 项目类别:
Protective Genetic Variants for Alzheimer Disease in the Amish
阿米什人阿尔茨海默病的保护性遗传变异
  • 批准号:
    9898659
  • 财政年份:
    2017
  • 资助金额:
    $ 58.26万
  • 项目类别:
Advancing Genetics Through the AMDgene Consortium
通过 AMDgene 联盟推进遗传学发展
  • 批准号:
    8265101
  • 财政年份:
    2012
  • 资助金额:
    $ 58.26万
  • 项目类别:
Advancing Genetics Through the AMDgene Consortium
通过 AMDgene 联盟推进遗传学发展
  • 批准号:
    8449079
  • 财政年份:
    2012
  • 资助金额:
    $ 58.26万
  • 项目类别:
Advancing Genetics Through the AMDgene Consortium
通过 AMDgene 联盟推进遗传学发展
  • 批准号:
    8655882
  • 财政年份:
    2012
  • 资助金额:
    $ 58.26万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政​​策的情绪动态
  • 批准号:
    10108433
  • 财政年份:
    2024
  • 资助金额:
    $ 58.26万
  • 项目类别:
    EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
  • 批准号:
    MR/X032809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.26万
  • 项目类别:
    Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
  • 批准号:
    MR/X034690/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.26万
  • 项目类别:
    Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
  • 批准号:
    2341426
  • 财政年份:
    2024
  • 资助金额:
    $ 58.26万
  • 项目类别:
    Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
  • 批准号:
    2341424
  • 财政年份:
    2024
  • 资助金额:
    $ 58.26万
  • 项目类别:
    Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
  • 批准号:
    2335955
  • 财政年份:
    2024
  • 资助金额:
    $ 58.26万
  • 项目类别:
    Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
  • 批准号:
    DP240103257
  • 财政年份:
    2024
  • 资助金额:
    $ 58.26万
  • 项目类别:
    Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
  • 批准号:
    DP240100408
  • 财政年份:
    2024
  • 资助金额:
    $ 58.26万
  • 项目类别:
    Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
  • 批准号:
    DP240100111
  • 财政年份:
    2024
  • 资助金额:
    $ 58.26万
  • 项目类别:
    Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
  • 批准号:
    502786
  • 财政年份:
    2024
  • 资助金额:
    $ 58.26万
  • 项目类别:
    Directed Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了